Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections

Cellular Microbiology

Volumn 16, Issue 8, 2014, Pages 1168-1178

  Deffert, Christine ^a,b   Cachat, Julien ^b   Krause, Karl Heinz ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ATYPICAL MYCOBACTERIUM; AUTOPHAGY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CHRONIC GRANULOMATOUS DISEASE; CYTOKINE PRODUCTION; DEFENSE MECHANISM; GRANULOMA; HUMAN; IN VITRO STUDY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; PHAGOLYSOSOME; PRIORITY JOURNAL; REVIEW; ANIMAL; EXTRACELLULAR TRAP; IMMUNOLOGY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; PATHOGENICITY; PATHOLOGY; PHAGOCYTOSIS; PHAGOSOME; TUBERCULOSIS, PULMONARY;

CORYNEBACTERINEAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; APOPTOSIS; EXTRACELLULAR TRAPS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; NADPH OXIDASE; PHAGOCYTOSIS; PHAGOSOMES; REACTIVE OXYGEN SPECIES; TUBERCULOSIS, PULMONARY;

EID: 84905053231     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12322     Document Type: Review

References (92)

1. Adams, L.B., Dinauer, M.C., Morgenstern, D.E., and Krahenbuhl, J.L. (1997) Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber Lung Dis 78: 237-246.
2. Afshar Paiman, S., Siadati, A., Mamishi, S., Tabatabaie, P., and Khotaee, G. (2006) Disseminated Mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol 5: 133-137.
3. Allen, D.M., and Chng, H.H. (1993) Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease. J Infect 26: 83-86.
4. Arkhipov, S.A., Shkurupy, V.A., Akhramenko, E.S., Solomatina, M.V., and Iljine, D.A. (2013) In vitro study of phenotypical characteristics of BCG granuloma macrophages over the course of granuloma development. Bull Exp Biol Med 155: 655-658.
5. Bakri, F.G., Martel, C., Khuri-Bulos, N., Mahafzah, A., El-Khateeb, M.S., Al-Wahadneh, A.M., etal. (2009) First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol 29: 215-230.
6. Bedard, K., and Krause, K.H. (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological reviews 87: 245-313.
7. van den Berg, J.M., van Koppen, E., Ahlin, A., Belohradsky, B.H., Bernatowska, E., Corbeel, L., etal. (2009) Chronic granulomatous disease: the European experience. PLoS ONE 4: e5234.
8. Bianchi, M., Niemiec, M.J., Siler, U., Urban, C.F., and Reichenbach, J. (2011) Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J Allergy Clin Immunol 127: 1243-1252.e7.
9. Borelli, V., Banfi, E., Perrotta, M.G., and Zabucchi, G. (1999) Myeloperoxidase exerts microbicidal activity against Mycobacterium tuberculosis. Infect Immun 67: 4149-4152.
10. Brosch, R., Gordon, S.V., Garnier, T., Eiglmeier, K., Frigui, W., Valenti, P., etal. (2007) Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 104: 5596-5601.
11. Bustamante, J., Aksu, G., Vogt, G., de Beaucoudrey, L., Genel, F., Chapgier, A., etal. (2007) BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol 120: 32-38.
12. Bustamante, J., Arias, A.A., Vogt, G., Picard, C., Galicia, L.B., Prando, C., etal. (2011a) Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 12: 213-221.
13. Bustamante, J., Picard, C., Boisson-Dupuis, S., Abel, L., and Casanova, J.-L. (2011b) Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases. Ann N Y Acad Sci 1246: 92-101.
14. Casanova, J.L., Jouanguy, E., Lamhamedi, S., Blanche, S., and Fischer, A. (1995) Immunological conditions of children with BCG disseminated infection. Lancet 346: 581.
15. Chan, J., Xing, Y., Magliozzo, R.S., and Bloom, B.R. (1992) Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175: 1111-1122.
16. Chusid, M.J., Parrillo, J.E., and Fauci, A.S. (1975) Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobacterium fortuitum. JAMA 233: 1295-1296.
17. Cifani, N., Pompili, B., Anile, M., Patella, M., Diso, D., Venuta, F., etal. (2013) Reactive-oxygen-species-mediated P. aeruginosa killing is functional in human cystic fibrosis macrophages. PLoS ONE 8: e71717.
18. Colangeli, R., Haq, A., Arcus, V.L., Summers, E., Magliozzo, R.S., McBride, A., etal. (2009) The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc Natl Acad Sci USA 106: 4414-4418.
19. Cooper, A.M., Segal, B.H., Frank, A.A., Holland, S.M., and Orme, I.M. (2000) Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. Infect Immun 68: 1231-1234.
20. Crisan, T.O., Plantinga, T.S., van de Veerdonk, F.L., Farcas, M.F., Stoffels, M., Kullberg, B.J., etal. (2011) Inflammasome-independent modulation of cytokine response by autophagy in human cells. PLoS ONE 6: e18666.
21. Deffert, C., Olleros, M.L., Huiping, Y., Herrmann, F.R., Zekry, D., Garcia, I., etal. (2011) TNF-alpha blockade in chronic granulomatous disease-induced hyperinflammation: patient analysis and murine model. J Allergy Clin Immunol 128: 675-677.
22. Deffert, C., Carnesecchi, S., Yuan, H., Rougemont, A.L., Kelkka, T., Holmdahl, R., etal. (2012) Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells. J Pathol 228: 341-350.
23. Deffert, C., Schäppi, M.G., Pache, J.C., Cachat, J., Vesin, D., Bisig, R., etal. (2014) Bacillus Calmette-Guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation. bioRxiv doi: 10.1101/005835.
24. Deretic, V. (2005) Autophagy in innate and adaptive immunity. Trends Immunol 26: 523-528.
25. Edwards, K.M., Cynamon, M.H., Voladri, R.K., Hager, C.C., DeStefano, M.S., Tham, K.T., etal. (2001) Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am J Respir Crit Care Med 164: 2213-2219.
26. Ehrt, S., and Schnappinger, D. (2009) Mycobacterial survival strategies in the phagosome: defence against host stresses. Cell Microbiol 11: 1170-1178.
27. Fattahi, F., Badalzadeh, M., Sedighipour, L., Movahedi, M., Fazlollahi, M.R., Mansouri, S.D., etal. (2011) Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol 31: 792-801.
28. Fazal, N. (1997) The role of reactive oxygen species (ROS) in the effector mechanisms of human antimycobacterial immunity. Biochem Mol Biol Int 43: 399-408.
29. Fujita, M., Harada, E., Matsumoto, T., Mizuta, Y., Ikegame, S., Ouchi, H., etal. (2010) Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease. Clin Exp Immunol 160: 457-460.
30. Galagan, J.E. (2014) Genomic insights into tuberculosis. Nat Rev Genet 15: 307-320.
31. von Goessel, H., Hossle, J.P., Seger, R., and Gungor, T. (2006) Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene. Exp Hematol 34: 528-535.
32. Gonzalez, B., Moreno, S., Burdach, R., Valenzuela, M.T., Henriquez, A., Ramos, M.I., and Sorensen, R.U. (1989) Clinical presentation of Bacillus Calmette-Guerin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J 8: 201-206.
33. Gonzalez-Cortes, C., Reyes-Ruvalcaba, D., Diez-Tascon, C., and Rivero-Lezcano, O.M. (2009) Apoptosis and oxidative burst in neutrophils infected with Mycobacterium spp. Immunol Lett 126: 16-21.
34. Gutierrez, M.G., Master, S.S., Singh, S.B., Taylor, G.A., Colombo, M.I., and Deretic, V. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766.
35. Harris, J., De Haro, S.A., Master, S.S., Keane, J., Roberts, E.A., Delgado, M., and Deretic, V. (2007) T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27: 505-517.
36. Hatanaka, E., Carvalho, B.T., Condino-Neto, A., and Campa, A. (2004) Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid A. Immunol Lett 94: 43-46.
37. Holland, S.M. (2013) Chronic granulomatous disease. Hematol Oncol Clin North Am 27: 89-99, viii.
38. Huang, J., and Brumell, J.H. (2009) NADPH oxidases contribute to autophagy regulation. Autophagy 5: 887-889.
39. Hultqvist, M., Olofsson, P., Gelderman, K.A., Holmberg, J., and Holmdahl, R. (2006) A new arthritis therapy with oxidative burst inducers. PLoS Med 3: e348.
40. Hultqvist, M., Olofsson, P., Wallner, F.K., and Holmdahl, R. (2014) Pharmacological potential of NOX2 agonists in inflammatory conditions. Antioxid Redox Signal doi:10.1089/ars.2013.5788.
41. Jacob, C.M., Pastorino, A.C., Azevedo, A.M., Marques, H.H., Sato, H.K., Ferrazole, L., etal. (1996) Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants. J Investig Allergol Clin Immunol 6: 202-206.
42. Jo, E.K. (2010) Innate immunity to mycobacteria: vitamin D and autophagy. Cell Microbiol 12: 1026-1035.
43. Jung, Y.J., LaCourse, R., Ryan, L., and North, R.J. (2002) Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice. J Exp Med 196: 991-998.
44. Kawashima, H., Hasegawa, D., Nakamura, M., Mochizuki, S., Kashiwagi, Y., Nishimata, S., etal. (2007) Hazards of early BCG vaccination: BCGitis in a patient with chronic granulomatous disease. Pediatr Int 49: 418-419.
45. Klebanoff, S.J., and Clark, R.A. (1978) The Neutrophil: Function and Clinical Disorders. Amsterdam: North-Holland Publishing Company.
46. Koker, M.Y., van Leeuwen, K., de Boer, M., Celmeli, F., Metin, A., Ozgur, T.T., etal. (2009) Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease. Eur J Clin Invest 39: 311-319.
47. Koker, M.Y., Camcioglu, Y., van Leeuwen, K., Kilic, S.S., Barlan, I., Yilmaz, M., etal. (2013) Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol 132: 1156-1163.e5.
48. Lau, Y.L., Chan, G.C., Ha, S.Y., Hui, Y.F., and Yuen, K.Y. (1998) The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis 26: 226-227.
49. Lee, P.P., Chan, K.W., Jiang, L., Chen, T., Li, C., Lee, T.L., etal. (2008) Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J 27: 224-230.
50. Lee, W.-I., Huang, J.-L., Lin, T.-Y., Hsueh, C., Wong, A., Hsieh, M.-Y., etal. (2009) Chinese patients with defective IL-12/23-interferon-γ circuit in Taiwan: partial dominant interferon-γ receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor β1 mutation as pneumatocele. J Clin Immunol 29: 238-245.
51. Li, H.M., Zhao, S.Y., He, J.X., and Jiang, Z.F. (2010) [Clinical analysis of 18 children with disseminated Bacille Calmette-Guerin infection]. Zhonghua Er Ke Za Zhi 48: 65-68.
52. Liu, W., Peng, Y., Yin, Y., Zhou, Z., Zhou, W., and Dai, Y. (2014) The involvement of NADPH oxidase-mediated ROS in cytokine secretion from macrophages induced by Mycobacterium tuberculosis ESAT-6. Inflammation 37: 880-892.
53. Lotte, A., Wasz-Hockert, O., Poisson, N., Dumitrescu, N., Verron, M., and Couvet, E. (1984) BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 21: 107-193.
54. de Luca, A., Smeekens, S.P., Casagrande, A., Iannitti, R., Conway, K.L., Gresnigt, M.S., etal. (2014) IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci USA 111: 3526-3531.
55. Marciano, B.E., Huang, C.Y., Joshi, G., Rezaei, N., Carvalho, B.C., Allwood, Z., etal. (2014) BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol 133: 1134-1141.
56. Mitroulis, I., Kourtzelis, I., Kambas, K., Chrysanthopoulou, A., and Ritis, K. (2011) Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype. Hum Immunol 72: 135-138.
57. Mouy, R., Fischer, A., Vilmer, E., Seger, R., and Griscelli, C. (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 114: 555-560.
58. Movahedi, M., Aghamohammadi, A., Rezaei, N., Shahnavaz, N., Babaei Jandaghi, A., Farhoudi, A., etal. (2004) Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian Primary Immunodeficiency Registry. Int Arch Allergy Immunol 134: 253-259.
59. Neeli, I., Khan, S.N., and Radic, M. (2008) Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 180: 1895-1902.
60. Ng, V.H., Cox, J.S., Sousa, A.O., MacMicking, J.D., and McKinney, J.D. (2004) Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol 52: 1291-1302.
61. Norouzi, S., Aghamohammadi, A., Mamishi, S., Rosenzweig, S.D., and Rezaei, N. (2012) Bacillus Calmette-Guerin (BCG) complications associated with primary immunodeficiency diseases. J Infect 64: 543-554.
62. Ohga, S., Ikeuchi, K., Kadoya, R., Okada, K., Miyazaki, C., Suita, S., and Ueda, K. (1997) Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease. J Infect 34: 147-150.
63. Parker, H., Dragunow, M., Hampton, M.B., Kettle, A.J., and Winterbourn, C.C. (2012) Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J Leukoc Biol 92: 841-849.
64. Perlmutter, A., Mittal, A., and Menter, A. (2009) Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians. Br J Dermatol 160: 8-15.
65. Perskvist, N., Long, M., Stendahl, O., and Zheng, L. (2002) Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. J Immunol 168: 6358-6365.
66. Piddington, D.L., Fang, F.C., Laessig, T., Cooper, A.M., Orme, I.M., and Buchmeier, N.A. (2001) Cu, Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun 69: 4980-4987.
67. Pizzolla, A., Hultqvist, M., Nilson, B., Grimm, M.J., Eneljung, T., Jonsson, I.M., etal. (2012) Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections. J Immunol 188: 5003-5011.
68. Placido, R., Auricchio, G., Falzoni, S., Battistini, L., Colizzi, V., Brunetti, E., etal. (2006) P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell Immunol 244: 10-18.
69. Ramos-Kichik, V., Mondragon-Flores, R., Mondragon-Castelan, M., Gonzalez-Pozos, S., Muniz-Hernandez, S., Rojas-Espinosa, O., etal. (2009) Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis 89: 29-37.
70. Sadeghi-Shanbestari, M., Ansarin, K., Maljaei, S.H., Rafeey, M., Pezeshki, Z., Kousha, A., etal. (2009) Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran. Ital J Pediatr 35: 42.
71. Sasindran, S.J., and Torrelles, J.B. (2011) Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium? Front Microbiol 2: 2.
72. Schaible, U.E., Sturgill-Koszycki, S., Schlesinger, P.H., and Russell, D.G. (1998) Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol 160: 1290-1296.
73. Schaible, U.E., Winau, F., Sieling, P.A., Fischer, K., Collins, H.L., Hagens, K., etal. (2003) Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 9: 1039-1046.
74. Schappi, M., Deffert, C., Fiette, L., Gavazzi, G., Herrmann, F., Belli, D., and Krause, K.H. (2008) Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice. J Pathol 214: 434-444.
75. Scoazec, J.Y., Fischer, A., and Nezelof, C. (1984) [Generalized BCG infection, expression of multifactorial deficiency of intramacrophage bactericidal action. Anatomo-clinical study of 11 cases]. Arch Fr Pediatr 41: 681-687.
76. Segal, B.H., Doherty, T.M., Wynn, T.A., Cheever, A.W., Sher, A., and Holland, S.M. (1999) The p47(phox-/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs. Infect Immun 67: 1659-1665.
77. Shahmohammadi, H.R., Bakar, J., Rahman, R.A., and Adzhan, N.M. (2014) Studying the effects of nucleating agents on texture modification of puffed corn-fish snack. J Food Sci 79: E178-E183.
78. Shi, S., and Ehrt, S. (2006) Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis. Infect Immun 74: 56-63.
79. Shin, D.M., Jeon, B.Y., Lee, H.M., Jin, H.S., Yuk, J.M., Song, C.H., etal. (2010) Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling. PLoS Pathog 6: e1001230.
80. Stasia, M.J., Bordigoni, P., Floret, D., Brion, J.P., Bost-Bru, C., Michel, G., etal. (2005) Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet 116: 72-82.
81. Teimourian, S., Rezvani, Z., Badalzadeh, M., Kannengiesser, C., Mansouri, D., Movahedi, M., etal. (2008) Molecular diagnosis of X-linked chronic granulomatous disease in Iran. Int J Hematol 87: 398-404.
82. Toida, I., and Nakata, S. (2007) [Severe adverse reactions after vaccination with Japanese BCG vaccine: a review]. Kekkaku 82: 809-824.
83. Via, L.E., Fratti, R.A., McFalone, M., Pagan-Ramos, E., Deretic, D., and Deretic, V. (1998) Effects of cytokines on mycobacterial phagosome maturation. J Cell Sci 111 (Part 7): 897-905.
84. Vieira, A.P., Vasconcelos, J., Fernandes, J.C., Antunes, H., Basto, A.S., Macedo, C., etal. (2004) Lymphadenopathy after BCG vaccination in a child with chronic granulomatous disease. Pediatr Dermatol 21: 646-651.
85. Voskuil, M.I., Bartek, I.L., Visconti, K., and Schoolnik, G.K. (2011) The response of mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front Microbiol 2: 105.
86. Weening, R.S., De Boer, M., Kuijpers, T.W., Neefjes, V.M., Hack, W.W., and Roos, D. (2000) Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease. Clin Exp Immunol 122: 410-417.
87. Wong, K.W., and Jacobs, W.R., Jr (2013) Mycobacterium tuberculosis exploits human interferon gamma to stimulate macrophage extracellular trap formation and necrosis. J Infect Dis 208: 109-119.
88. Yang, C.S., Shin, D.M., Kim, K.H., Lee, Z.W., Lee, C.H., Park, S.G., etal. (2009) NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J Immunol 182: 3696-3705.
89. Yang, C.S., Lee, J.S., Rodgers, M., Min, C.K., Lee, J.Y., Kim, H.J., etal. (2012) Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe 11: 264-276.
90. Ying, W.J., Wang, X.C., Sun, J.Q., Liu, D.R., Yu, Y.H., and Wang, J.Y. (2012) [Clinical features of chronic granulomatous disease]. Zhonghua Er Ke Za Zhi 50: 380-385.
91. Yu, K., Mitchell, C., Xing, Y., Magliozzo, R.S., Bloom, B.R., and Chan, J. (1999) Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber Lung Dis 79: 191-198.
92. Zhang, Y., Choksi, S., Chen, K., Pobezinskaya, Y., Linnoila, I., and Liu, Z.G. (2013) ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res 23: 898-914.